SARAH WESSELIUS: Open Payments
NPI 1336728609 · BRIGHTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 19 payments from 12 companies in 2025. Trend: 2023 $330 · 2024 $499 · 2025 $672
Food & beverage: $579Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $200 |
| Daiichi Sankyo Inc. | 1 | $110 |
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| Eisai Inc. | 2 | $55 |
| PFIZER INC. | 1 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| SOBI, INC | 1 | $29 |
| ABBVIE INC. | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
Products named: RYBREVANT, Enhertu, Lenvima, PADCEV, OJJAARA, Vonjo, EPKINLY, ERLEADA.
Industry payments across CO — which companies pay providers there.
